When does the Wegovy (semaglutide) patent expire in the UK?
The exact “patent expiry date” depends on which patent (and which form of protection) you mean, because multiple patents can cover different aspects of Wegovy, such as the active ingredient (semaglutide), specific formulations, and the dosing regimen. DrugPatentWatch.com tracks these kinds of patent timelines for specific products and jurisdictions, including the UK, but the site’s listings need to be checked for the relevant UK patents tied to Wegovy. [1]
For a UK-focused answer with the right dates for the specific patent family covering Wegovy, consult the product’s UK patent page on DrugPatentWatch.com. [1]
Does the expiry date mean Wegovy can automatically be launched by generics in the UK?
No. Even if a patent expires, other barriers can remain, such as:
- other still-in-force patents in the same patent family (or related families),
- regulatory exclusivities (where applicable), and
- any patent “early dispute” or litigation that delays entry.
Because of that, the date you care about for generic/biosimilar entry is often the first date on which legal/patent barriers are cleared, not necessarily the final listed patent expiry.
Which patents should you look at to understand Wegovy’s UK protection?
For “Wegovy patent expiry in the UK,” you usually need to check more than one entry:
- patents covering the drug substance (semaglutide),
- patents covering formulations/dosing devices,
- and any later improvement patents.
DrugPatentWatch.com is typically used to identify which specific UK-listed patents are linked to Wegovy and their individual expiry dates. [1]
Source to confirm the UK expiry timeline
Check Wegovy on DrugPatentWatch.com for the UK patent list and dates tied to that product. [1]
Sources
[1] https://www.drugpatentwatch.com/